McKesson Corporation (LON:0JZU)
825.99
+15.59 (1.92%)
At close: Dec 19, 2025
McKesson Revenue
McKesson had revenue of $103.15B USD in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $387.09B, up 17.23% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$387.09B
Revenue Growth
+17.23%
P/S Ratio
0.26
Revenue / Employee
$8.60M
Employees
45,000
Market Cap
75.70B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
| Mar 31, 2019 | 214.32B | 5.96B | 2.86% |
| Mar 31, 2018 | 208.36B | 9.82B | 4.95% |
| Mar 31, 2017 | 198.53B | 7.65B | 4.01% |
| Mar 31, 2016 | 190.88B | 11.84B | 6.61% |
| Mar 31, 2015 | 179.05B | 41.65B | 30.32% |
| Mar 31, 2014 | 137.39B | 15.20B | 12.44% |
| Mar 31, 2013 | 122.20B | -125.00M | -0.10% |
| Mar 31, 2012 | 122.32B | 10.24B | 9.13% |
| Mar 31, 2011 | 112.08B | 3.38B | 3.11% |
| Mar 31, 2010 | 108.70B | 2.07B | 1.94% |
| Mar 31, 2009 | 106.63B | 4.93B | 4.85% |
| Mar 31, 2008 | 101.70B | 8.73B | 9.39% |
| Mar 31, 2007 | 92.98B | 5.99B | 6.89% |
| Mar 31, 2006 | 86.98B | 7.89B | 9.97% |
| Mar 31, 2005 | 79.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
McKesson News
- 19 hours ago - Our Top 10 High-Growth Dividend Stocks - December 2025 - Seeking Alpha
- 2 days ago - Interesting MCK Put And Call Options For August 2026 - Nasdaq
- 5 days ago - McKesson (MCK) Rises As Market Takes a Dip: Key Facts - Nasdaq
- 5 days ago - If You Invested $100 In McKesson Stock 20 Years Ago, You Would Have This Much Today - Benzinga
- 10 days ago - Is Trending Stock McKesson Corporation (MCK) a Buy Now? - Nasdaq
- 11 days ago - Barclays Initiates Coverage on McKesson (MCK) with Overweight Rating | MCK Stock News - GuruFocus
- 12 days ago - Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock - Benzinga
- 15 days ago - If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today - Benzinga